PAK1, a prototype of group I PAKs, was known to function in the key steps of human cancer progression; and its roles were well studied in multiple malignancies, including breast cancer, colon cancer, lung cancer, melanoma, prostate cancer, ovarian cancer and TSCC [30, 31]. Here, PAK1 is linked to breast carcinoma.